Video: Insights from a CCO: Evolving oncology market dynamics and expediting therapy to metastatic HER2-positive breast cancer patients

Oncology Chief Commercialization Officer, Suzanne Greenwood, shares insights on evolving oncology market dynamics and expediting therapy to metastatic HER2-positive breast cancer patients


Watch the full 60-minute virtual panel, “Next Gen Commercial Models in Oncology,” PharmaVOICE Editor Taren Grom sat down with industry leaders to discuss how changing market dynamics and a rich pipeline in oncology are creating a need for next gen commercial models.

https://sandbox.eversana.com/insights/pharmavoice-webinar-next-gen-commercialization-model-for-oncology/